163 related articles for article (PubMed ID: 33619332)
1. Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant.
Yelskaya Z; Arnold AG; Marcell VJ; Tang LH; Salo-Mullen EE; Strong VE; Stadler ZK; Zhang L
Eur J Hum Genet; 2021 Jul; 29(7):1103-1109. PubMed ID: 33619332
[TBL] [Abstract][Full Text] [Related]
2. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
[TBL] [Abstract][Full Text] [Related]
3. CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site.
Yelskaya Z; Bacares R; Salo-Mullen E; Somar J; Lehrich DA; Fasaye GA; Coit DG; Tang LH; Stadler ZK; Zhang L
PLoS One; 2016; 11(11):e0165654. PubMed ID: 27880784
[TBL] [Abstract][Full Text] [Related]
4. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
5. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
6. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
7. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
[TBL] [Abstract][Full Text] [Related]
8. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P
Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870
[TBL] [Abstract][Full Text] [Related]
9.
Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
[TBL] [Abstract][Full Text] [Related]
10. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
13. Family's History Based on the
Caggiari L; Fornasarig M; De Zorzi M; Cannizzaro R; Steffan A; De Re V
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664545
[TBL] [Abstract][Full Text] [Related]
14. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
[TBL] [Abstract][Full Text] [Related]
16. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum and pleiotropic nature of
Figueiredo J; Melo S; Carneiro P; Moreira AM; Fernandes MS; Ribeiro AS; Guilford P; Paredes J; Seruca R
J Med Genet; 2019 Apr; 56(4):199-208. PubMed ID: 30661051
[No Abstract] [Full Text] [Related]
18. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
[TBL] [Abstract][Full Text] [Related]
19. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
20. PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS.
Tabassum S; Munir F; Al Awadh AA; Anwar Z
Exp Oncol; 2023 Oct; 45(2):170-179. PubMed ID: 37824775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
